The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke

Brain Research

Volumn 1353, Issue , 2010, Pages 1-13

  Cho, Goang Won ^a   Koh, Seong Ho ^a   Kim, Mi Hwa ^a   Yoo, A Rum ^a   Noh, Min Young ^a   Oh, Sechul ^a   Kim, Seung Hyun ^a  

^a Hanyang University   (South Korea)

Author keywords

Ischemic stroke; Neuroprotection; Neurotrophic factor; Stem cell therapy

Indexed keywords

5' NUCLEOTIDASE; ALPHA3 INTEGRIN; ANGIOPOIETIN 1; ANTIOXIDANT; BETA1 INTEGRIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CD34 ANTIBODY; CD44V ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HLA DR ANTIGEN; HYDROGEN PEROXIDE; PLACENTAL GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN; SCATTER FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; CELL SELECTION; CELL SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LENTIVIRUS INFECTION; MESENCHYMAL STEM CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; VASCULAR SURGERY; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; BRAIN INFARCTION; CASPASE 3; CELL DEATH; CELL LINE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGEN PEROXIDE; INFARCTION, MIDDLE CEREBRAL ARTERY; LENTIVIRUS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NERVE GROWTH FACTORS; NERVOUS SYSTEM DISEASES; RATS; STATISTICS, NONPARAMETRIC; TETRAZOLIUM SALTS; THIAZOLES; TRANSDUCTION, GENETIC;

ANIMALIA;

EID: 77956393300     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.06.013     Document Type: Article

References (40)

1. D. Agnello, P. Bigini, P. Villa, T. Mennini, A. Cerami, M.L. Brines, and P. Ghezzi Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis Brain Res. 952 2002 128 134
2. H. Ay, E.M. Arsava, S.C. Johnston, M. Vangel, L.H. Schwamm, K.L. Furie, W.J. Koroshetz, and A.G. Sorensen Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model Stroke 40 2009 181 186
3. S.A. Azizi, D. Stokes, B.J. Augelli, C. DiGirolamo, and D.J. Prockop Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts Proc. Natl Acad. Sci. USA 95 1998 3908 3913
4. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. de Lanerolle, C. Cerami, L.M. Itri, and A. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc. Natl Acad. Sci. USA 97 2000 10526 10531
5. V.C. Broudy, N. Lin, M. Brice, B. Nakamoto, and T. Papayannopoulou Erythropoietin receptor characteristics on primary human erythroid cells Blood 77 1991 2583 2590
6. T.L. Burgess, and R.B. Kelly Constitutive and regulated secretion of proteins Annu. Rev. Cell Biol. 3 1987 243 293
7. M. Celik, N. Gokmen, S. Erbayraktar, M. Akhisaroglu, S. Konakc, C. Ulukus, S. Genc, K. Genc, E. Sagiroglu, A. Cerami, and M. Brines Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc. Natl Acad. Sci. USA 99 2002 2258 2263
8. X. Chen, Y. Li, L. Wang, M. Katakowski, L. Zhang, J. Chen, Y. Xu, S.C. Gautam, and M. Chopp Ischemic rat brain extracts induce human marrow stromal cell growth factor production Neuropathology 22 2002 275 279
9. J. Chen, Y. Li, M. Katakowski, X. Chen, L. Wang, D. Lu, M. Lu, S.C. Gautam, and M. Chopp Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat J. Neurosci. Res. 73 2003 778 786
10. Z.Z. Chong, J.Q. Kang, and K. Maiese Erythropoietin: cytoprotection in vascular and neuronal cells Curr. Drug Targets Cardiovasc. Haematol. Disord. 3 2003 141 154
11. I.B. Copland, E.M. Jolicoeur, M.A. Gillis, J. Cuerquis, N. Eliopoulos, B. Annabi, A. Calderone, J.F. Tanguay, A. Ducharme, and J. Galipeau Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties Cardiovasc. Res. 79 2008 405 415
12. H. Ehrenreich, K. Weissenborn, H. Prange, D. Schneider, C. Weimar, K. Wartenberg, P.D. Schellinger, M. Bohn, H. Becker, M. Wegrzyn, P. Jahnig, M. Herrmann, M. Knauth, M. Bahr, W. Heide, A. Wagner, S. Schwab, H. Reichmann, G. Schwendemann, R. Dengler, A. Kastrup, and C. Bartels Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 2009 e647 e656
13. N. Eliopoulos, R.F. Gagnon, M. Francois, and J. Galipeau Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure J. Am. Soc. Nephrol. 17 2006 1576 1584
14. S. Genc, M. Akhisaroglu, F. Kuralay, and K. Genc Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro Neurosci. Lett. 321 2002 73 76
15. A. Gorio, N. Gokmen, S. Erbayraktar, O. Yilmaz, L. Madaschi, C. Cichetti, A.M. Di Giulio, E. Vardar, A. Cerami, and M. Brines Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma Proc. Natl Acad. Sci. USA 99 2002 9450 9455
16. W. Hong, and B.L. Tang Protein trafficking along the exocytotic pathway Bioessays 15 1993 231 238
17. Y. Horita, O. Honmou, K. Harada, K. Houkin, H. Hamada, and J.D. Kocsis Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat J. Neurosci. Res. 84 2006 1495 1504
18. Y. Hua, T. Schallert, R.F. Keep, J. Wu, J.T. Hoff, and G. Xi Behavioral tests after intracerebral hemorrhage in the rat Stroke 33 2002 2478 2484
19. Z. Kadri, L. Maouche-Chretien, H.M. Rooke, S.H. Orkin, P.H. Romeo, P. Mayeux, P. Leboulch, and S. Chretien Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation Mol. Cell. Biol. 25 2005 7412 7422
20. M. Kimura, A. Takatsuki, and I. Yamaguchi Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells Biochim. Biophys. Acta 1219 1994 653 659
21. M. Kobune, Y. Kawano, Y. Ito, H. Chiba, K. Nakamura, H. Tsuda, K. Sasaki, H. Dehari, H. Uchida, O. Honmou, S. Takahashi, A. Bizen, R. Takimoto, T. Matsunaga, J. Kato, K. Kato, K. Houkin, Y. Niitsu, and H. Hamada Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells Exp. Hematol. 31 2003 715 722
22. S.H. Koh, Y. Park, C.W. Song, J.G. Kim, K. Kim, J. Kim, M.H. Kim, S.R. Lee, D.W. Kim, H.J. Yu, D.I. Chang, S.J. Hwang, and S.H. Kim The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals Eur. J. Neurosci. 20 2004 1461 1472
23. S.H. Koh, Y. Kim, H.Y. Kim, G.W. Cho, K.S. Kim, and S.H. Kim Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation Eur. J. Neurosci. 25 2007 1923 1930
24. S.H. Koh, K.S. Kim, M.R. Choi, K.H. Jung, K.S. Park, Y.G. Chai, W. Roh, S.J. Hwang, H.J. Ko, Y.M. Huh, H.T. Kim, and S.H. Kim Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats Brain Res. 1229 2008 233 248
25. S.H. Koh, A.R. Yoo, D.I. Chang, S.J. Hwang, and S.H. Kim Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions Biochem. Biophys. Res. Commun. 371 2008 894 899
26. S.H. Koh, M.Y. Noh, G.W. Cho, K.S. Kim, and S.H. Kim Erythropoietin increases the motility of human bone marrow multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs Stem Cells Dev. 18 2009 411 421
27. H.J. Lee, K.S. Kim, I.H. Park, and S.U. Kim Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model PLoS ONE 2 2007 e156
28. H. Liu, O. Honmou, K. Harada, K. Nakamura, K. Houkin, H. Hamada, and J.D. Kocsis Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia Brain 129 2006 2734 2745
29. M. McLeod, M. Hong, K. Mukhida, D. Sadi, R. Ulalia, and I. Mendez Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease Eur. J. Neurosci. 24 2006 361 370
30. Y. Miki, N. Nonoguchi, N. Ikeda, R.S. Coffin, T. Kuroiwa, and S. Miyatake Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia Neurosurgery 61 2007 586 594 discussion 594-5
31. T. Nomura, O. Honmou, K. Harada, K. Houkin, H. Hamada, and J.D. Kocsis I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat Neuroscience 136 2005 161 169
32. T. Onda, O. Honmou, K. Harada, K. Houkin, H. Hamada, and J.D. Kocsis Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia J. Cereb. Blood Flow Metab. 28 2008 329 340
33. T.J. Stoller, and D. Shields The propeptide of preprosomatostatin mediates intracellular transport and secretion of alpha-globin from mammalian cells J. Cell Biol. 108 1989 1647 1655
34. Y. Sun, J.W. Calvert, and J.H. Zhang Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration Stroke 36 2005 1672 1678
35. P. Villa, P. Bigini, T. Mennini, D. Agnello, T. Laragione, A. Cagnotto, B. Viviani, M. Marinovich, A. Cerami, T.R. Coleman, M. Brines, and P. Ghezzi Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis J. Exp. Med. 198 2003 971 975
36. B. Viviani, S. Bartesaghi, E. Corsini, P. Villa, P. Ghezzi, A. Garau, C.L. Galli, and M. Marinovich Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor J. Neurochem. 93 2005 412 421
37. M.R. Ward, and D.J. Stewart Erythropoietin and mesenchymal stromal cells in angiogenesis and myocardial regeneration: one plus one equals three? Cardiovasc. Res. 79 2008 357 359
38. D. Woodbury, E.J. Schwarz, D.J. Prockop, and I.B. Black Adult rat and human bone marrow stromal cells differentiate into neurons J. Neurosci. Res. 61 2000 364 370
39. A. Xenocostas, W.K. Cheung, F. Farrell, C. Zakszewski, M. Kelley, A. Lutynski, M. Crump, J.H. Lipton, T.L. Kiss, C.Y. Lau, and H.A. Messner The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin Eur. J. Clin. Pharmacol. 61 2005 189 195
40. M.Z. Zhao, N. Nonoguchi, N. Ikeda, T. Watanabe, D. Furutama, D. Miyazawa, H. Funakoshi, Y. Kajimoto, T. Nakamura, M. Dezawa, M.A. Shibata, Y. Otsuki, R.S. Coffin, W.D. Liu, T. Kuroiwa, and S. Miyatake Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector J. Cereb. Blood Flow Metab. 26 2006 1176 1188